middl
east
respiratori
syndrom
coronaviru
member
betacoronaviru
genu
lineag
c
first
identifi
saudi
arabia
januari
human
case
report
includ
least
death
multipl
studi
suggest
dromedari
camel
major
sourc
human
infect
antibodi
detect
serum
dromedari
camel
across
northern
africa
includ
tunisia
egypt
sudan
ethiopia
nigeria
kenya
somalia
across
arabian
peninsula
includ
jordan
saudi
arabia
qatar
oman
unit
arab
emir
corman
et
al
hemida
et
al
meyer
et
al
muller
et
al
neutral
antibodi
detect
archiv
camel
serum
sampl
suggest
circul
dromedari
region
muller
et
al
genom
detect
isol
sequenc
camel
respiratori
specimen
northern
africa
nigeria
saudi
arabia
air
sampl
camel
barn
own
known
human
alagaili
et
al
azhar
et
al
chu
et
al
haagman
et
al
raj
et
al
genom
epidemiolog
studi
compar
sequenc
household
cluster
camel
dromedari
farm
human
contact
uae
muhairi
et
al
paden
et
al
patient
correspond
camel
saudi
arabia
kasem
et
al
demonstr
camel
potenti
sourc
human
infect
israel
geograph
locat
middl
east
border
jordan
human
case
report
antibodi
detect
serum
dromedari
camel
suggest
isra
citizen
may
risk
infect
howev
date
ill
report
israel
seropreval
antibodi
isra
dromedari
camel
unknown
object
studi
determin
preval
seroposit
isra
camel
serum
specimen
dromedari
camel
across
four
differ
locat
israel
site
tabl
collect
may
june
previous
describ
rasi
rudol
schwartz
giladi
farm
n
locat
east
jerusalem
farm
n
respect
locat
negev
desert
southern
israel
origin
camel
prior
associ
four
locat
unknown
camel
use
tourism
industri
studi
includ
male
n
femal
n
camel
age
year
old
blood
sampl
taken
jugular
vein
punctur
serum
sampl
obtain
day
collect
unclot
blood
use
serum
separ
tube
serum
specimen
ship
cdc
inactiv
gamma
irradi
rad
cobalt
irradi
inactiv
potenti
pathogen
store
use
studi
approv
tel
aviv
souraski
medic
center
institut
anim
care
use
committe
studi
neutral
mnt
assay
perform
determin
presenc
neutral
antibodi
camel
sera
use
jordan
strain
follow
previous
establish
method
sui
et
al
initi
mnt
assay
perform
use
titrat
rang
sampl
mnt
titr
titrat
mnt
perform
use
polyclon
guinea
pig
coronaviru
mebu
strain
nih
biodenfens
emerg
infect
research
resourc
repositori
antiserum
evalu
antibodi
initi
ifa
screen
perform
use
sera
dilut
follow
modifi
previous
publish
protocol
corman
et
al
briefli
jordan
vero
cell
slide
fix
permeabil
block
whole
camel
serum
abcam
incub
serum
stain
llama
igg
h
l
bethyl
lab
figur
whole
camel
block
serum
screen
absenc
specimen
verifi
block
result
fals
posit
signal
specimen
indetermin
presenc
antibodi
final
indetermin
determin
made
two
independ
screen
ifa
indetermin
ifa
titr
determin
repeat
screen
serial
dilut
camel
sera
reactiv
bcov
mebu
strain
assess
use
commerci
avail
ifa
kit
veterinari
medic
research
develop
statist
analys
perform
use
fisher
exact
test
consid
signific
camel
sera
neutral
antibodi
titr
tabl
serum
sampl
high
neutral
antibodi
titr
rang
tabl
ifa
titr
rang
greater
tabl
neutral
titr
increas
n
titr
determin
ifa
also
increas
sixteen
camel
lower
serum
neutral
antibodi
titr
rang
tabl
camel
ifa
titr
equal
three
camel
tabl
figur
less
six
camel
indetermin
remain
seven
camel
remain
camel
serum
neutral
antibodi
titr
less
level
detect
antibodi
titr
ifa
either
n
figur
indetermin
n
data
shown
attempt
detect
coronaviru
genom
materi
camel
sera
unsuccess
inabl
detect
genom
materi
may
part
due
three
key
factor
studi
one
specimen
collect
optim
nucleic
acid
preserv
two
prior
studi
sera
irradi
rad
upon
arriv
cdc
per
import
requir
three
camel
may
acut
infect
time
serum
collect
presenc
antibodi
determin
randomli
select
subset
camel
sera
neutral
antibodi
titr
n
titr
n
bcov
ifa
use
dilut
camel
sera
nine
camel
microneutr
titr
neg
serum
antibodi
includ
one
camel
neutral
titr
three
indetermin
remain
sera
demonstr
reactiv
bcov
fourteen
camel
detect
neutral
antibodi
titr
titr
posit
antibodi
dilut
serum
antibodi
dromedari
camel
saudi
arabia
demonstr
reactiv
bovin
coronaviru
bcov
hemida
et
al
perera
et
al
suggest
presenc
bcov
antibodi
may
impair
abil
specif
detect
antibodi
howev
antibodi
specif
neutral
bcov
infect
antibodi
neutral
infect
hemida
et
al
perera
et
al
consist
find
antiserum
bcov
mnt
use
studi
confirm
specif
assay
discrimin
two
virus
data
shown
associ
neutral
antibodi
gender
age
camel
locat
number
neutral
antibodi
posit
camel
significantli
higher
site
c
p
respect
compar
site
b
significantli
higher
site
c
p
significantli
higher
site
p
specimen
test
bcov
indetermin
specimen
n
origin
site
posit
antibodi
find
demonstr
high
neutral
antibodi
titr
suggest
relat
viru
circul
dromedari
camel
israel
extend
known
geograph
rang
circul
camel
result
rule
antibodi
inabl
bcov
immun
sera
neutral
suggest
presenc
antibodi
appear
impact
abil
specif
detect
mnt
circul
close
relat
viru
dromedari
camel
israel
absenc
report
clinic
case
isra
popul
suggest
may
factor
involv
dynam
transmiss
beyond
circul
within
camel
herd
author
conflict
interest
declar
